PRIMA EU Retrospective & Prospective

  • Research type

    Research Study

  • Full title

    A multicentric study evaluating clinical and radiological outcomes of PRIMA humeral stem in total shoulder arthroplasty

  • IRAS ID

    349475

  • Contact name

    Amar Malhas

  • Contact email

    Amar.Malhas@royalberkshire.nhs.uk

  • Sponsor organisation

    Limacorporate spa

  • Clinicaltrials.gov Identifier

    NCT06371833

  • Duration of Study in the UK

    2 years, 11 months, 30 days

  • Research summary

    Total shoulder arthroplasty (TSA) is a surgery to treat severe shoulder joint diseases to relieve pain and restore shoulder function. Conventional artificial shoulder implants often lead to complications especially related to the stem. The PRIMA system consists of a 3D-printed short stem that can be used for both regular and reverse shoulder replacements. This study aims to evaluate the performance and safety of the PRIMA humeral stem over 24 months, looking at clinical outcomes, patient feedback, X-ray results, and the overall durability of the implant.
    The study aims to see how patients feel about their shoulder replacements with the PRIMA humeral stem over 24 months. It will also look at X-ray results and check the stability of the implant, evaluate its safety, and see how well the implant lasts over this period.

  • REC name

    London - Stanmore Research Ethics Committee

  • REC reference

    25/LO/0433

  • Date of REC Opinion

    28 Jul 2025

  • REC opinion

    Further Information Favourable Opinion